13vPnC
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Vaccines
Conditions
Vaccines
Trial Timeline
May 31, 2018 → Dec 20, 2019
NCT ID
NCT03548337About 13vPnC
13vPnC is a approved stage product being developed by Pfizer for Vaccines. The current trial status is completed. This product is registered under clinical trial identifier NCT03548337. Target conditions include Vaccines.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03777865 | Approved | Completed |
| NCT03548337 | Approved | Completed |
| NCT00562354 | Phase 3 | Completed |
| NCT00574795 | Phase 3 | Completed |
Competing Products
20 competing products in Vaccines